Tundra Space

Tundra Space

Clinical Research Directory

Browse clinical research sites, groups, and studies.

Back to Studies
NOT YET RECRUITING
NCT07566286
NA

Study to Evaluate the Safety of Retreatment With Restylane® Lyft With Lidocaine for Augmentation of the Chin Region

Sponsor: Galderma R&D

View on ClinicalTrials.gov

Summary

The primary objective of this study is to evaluate the safety of Restylane Lyft with Lidocaine for augmentation of the chin region 3 months after retreatment.

Official title: A Prospective, Multicenter Study to Evaluate the Safety of Retreatment With Restylane® Lyft With Lidocaine for Augmentation of the Chin Region to Improve the Chin Profile

Key Details

Gender

All

Age Range

22 Years - Any

Study Type

INTERVENTIONAL

Enrollment

100

Start Date

2026-06-03

Completion Date

2028-02-28

Last Updated

2026-06-22

Healthy Volunteers

Yes

Interventions

DEVICE

Restylane Lyft with Lidocaine

Sterile gel of hyaluronic acid.

Locations (8)

Galderma Investigational Site # 8680

Westport, Connecticut, United States

Galderma Investigational Site # 8774

Boynton Beach, Florida, United States

Galderma Investigational Site # 7030

Coral Gables, Florida, United States

Galderma Investigational Site # 8682

Coral Gables, Florida, United States

Galderma Investigational Site # 7042

Atlanta, Georgia, United States

Galderma Investigational Site # 7043

Bethesda, Maryland, United States

Galderma Investigational Site # 7118

Nashville, Tennessee, United States

Galderma Investigational Site # 8662

Spring, Texas, United States